| Foreword |
|
vii | |
| Preface |
|
ix | |
| Acknowledgment |
|
xi | |
| Contributors |
|
xiii | |
|
|
|
1 | (25) |
|
|
|
|
|
|
|
1 | (9) |
|
|
|
10 | (5) |
|
|
|
15 | (2) |
|
|
|
17 | (1) |
|
|
|
18 | (3) |
|
|
|
21 | (5) |
|
|
|
26 | (17) |
|
|
|
|
|
|
|
Pulmonary Thromboembolism (PTE) |
|
|
26 | (1) |
|
Bronchogenic Carcinoma (Lung Cancer) |
|
|
27 | (1) |
|
|
|
27 | (1) |
|
|
|
28 | (1) |
|
|
|
29 | (1) |
|
Pulmonary Function and Diagnosis |
|
|
29 | (1) |
|
Obstructive Pulmonary Disease |
|
|
30 | (1) |
|
|
|
31 | (2) |
|
|
|
33 | (1) |
|
|
|
34 | (1) |
|
Pneumonia and Infections of the Lung |
|
|
34 | (2) |
|
Diffuse Parenchymal Lung Disease (aka Interstitial Disease) |
|
|
36 | (2) |
|
|
|
38 | (5) |
|
Heart and Blood Vessel Disorders |
|
|
43 | (31) |
|
|
|
|
|
43 | (2) |
|
|
|
45 | (1) |
|
|
|
46 | (2) |
|
Acute Myocardial Infarction (AMI) |
|
|
48 | (1) |
|
|
|
49 | (1) |
|
Valvular Heart Disease (VHD) |
|
|
50 | (4) |
|
|
|
54 | (1) |
|
|
|
54 | (1) |
|
Rheumatic Fever and Heart Disease |
|
|
55 | (1) |
|
|
|
56 | (1) |
|
Chronic Occlusive Arterial Disease/Peripheral Arterial Disease |
|
|
57 | (1) |
|
Acute Embolic Occlusive Arterial Disease |
|
|
57 | (1) |
|
|
|
58 | (1) |
|
Chronic Venous Insufficiency |
|
|
58 | (1) |
|
Superficial Thrombophlebitis |
|
|
58 | (1) |
|
Deep Vein Thrombosis and Thrombophlebitis (DVT) |
|
|
59 | (1) |
|
Hyperlipidemia and Dyslipoproteinemia |
|
|
59 | (1) |
|
|
|
60 | (2) |
|
|
|
62 | (1) |
|
Giant Cell Arteritis (Also Called Cranial Arteritis and Temporal Arteritis) |
|
|
63 | (1) |
|
|
|
63 | (2) |
|
|
|
65 | (9) |
|
Gastrointestinal Disorders |
|
|
74 | (17) |
|
|
|
Disorders of the Esophagus |
|
|
74 | (4) |
|
Disorders of the Stomach and Intestines |
|
|
78 | (6) |
|
|
|
84 | (1) |
|
Disorders of the Liver and Pancreas |
|
|
85 | (6) |
|
|
|
91 | (33) |
|
|
|
|
|
|
|
|
|
91 | (4) |
|
|
|
95 | (6) |
|
|
|
101 | (5) |
|
|
|
106 | (5) |
|
|
|
111 | (4) |
|
|
|
115 | (3) |
|
|
|
118 | (1) |
|
Specific Substance-Use and Substance-Induced Disorders |
|
|
118 | (6) |
|
|
|
124 | (19) |
|
|
|
Margaret L. Fenner-Gulledge |
|
|
|
|
|
|
124 | (2) |
|
|
|
126 | (1) |
|
|
|
127 | (1) |
|
|
|
128 | (2) |
|
|
|
130 | (2) |
|
Movement/Neuromuscular Disorders |
|
|
132 | (2) |
|
|
|
134 | (1) |
|
|
|
135 | (2) |
|
Nonorganic Headache Syndromes |
|
|
137 | (1) |
|
|
|
138 | (5) |
|
Musculoskeletal Disorders |
|
|
143 | (31) |
|
|
|
|
|
|
|
143 | (1) |
|
|
|
144 | (7) |
|
Inherited or Developmental Disorders |
|
|
151 | (3) |
|
|
|
154 | (1) |
|
|
|
155 | (12) |
|
|
|
167 | (7) |
|
|
|
174 | (24) |
|
|
|
|
|
|
|
174 | (6) |
|
|
|
180 | (2) |
|
Viral Infections of the Skin |
|
|
182 | (6) |
|
Bacterial Infections of the Skin |
|
|
188 | (3) |
|
Mycotic Infections of the Skin, Hair, and Nails |
|
|
191 | (3) |
|
Parasitic Infestations of Skin and Hair |
|
|
194 | (4) |
|
|
|
198 | (16) |
|
Daniela Cheles-Livingston |
|
|
|
|
198 | (2) |
|
|
|
200 | (3) |
|
|
|
203 | (1) |
|
|
|
203 | (2) |
|
|
|
205 | (2) |
|
Disorders of Adrenal Medulla |
|
|
207 | (1) |
|
Diabetes Mellitus (DM) and Hypoglycemia |
|
|
207 | (4) |
|
|
|
211 | (1) |
|
Multiple Endocrine Neoplasia (MEN) |
|
|
211 | (1) |
|
Paraneoplastic Endocrine Syndromes |
|
|
211 | (3) |
|
Renal and Urinary Tract Disorders |
|
|
214 | (23) |
|
|
|
|
|
|
|
|
|
214 | (1) |
|
|
|
215 | (1) |
|
|
|
215 | (2) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
218 | (1) |
|
Cystic Diseases of the Kidney |
|
|
219 | (1) |
|
Renal Vascular Hypertension |
|
|
220 | (1) |
|
|
|
220 | (1) |
|
Chronic Renal Failure (CRF) |
|
|
221 | (1) |
|
|
|
222 | (1) |
|
Acute Tubulointerstitial Nephritis |
|
|
223 | (1) |
|
Chronic Tubulointerstitial Nephritis |
|
|
223 | (1) |
|
|
|
224 | (1) |
|
|
|
225 | (1) |
|
|
|
226 | (1) |
|
|
|
227 | (1) |
|
|
|
228 | (1) |
|
|
|
229 | (1) |
|
Disorders of Calcium Concentration |
|
|
230 | (2) |
|
|
|
232 | (3) |
|
Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Secretion |
|
|
235 | (2) |
|
Male and Female Reproductive Disorders |
|
|
237 | (20) |
|
Male Reproductive Disorders |
|
|
237 | (1) |
|
Jose (``Pepe'') E. Barcega |
|
|
|
|
237 | (2) |
|
|
|
239 | (1) |
|
Disorders of the Prostate |
|
|
240 | (1) |
|
Disorders of Testosterone Secretion |
|
|
241 | (1) |
|
Female Reproductive Disorders |
|
|
241 | (1) |
|
|
|
|
|
|
|
241 | (4) |
|
|
|
245 | (1) |
|
|
|
246 | (1) |
|
|
|
247 | (1) |
|
|
|
248 | (1) |
|
|
|
249 | (1) |
|
|
|
249 | (2) |
|
|
|
251 | (1) |
|
|
|
252 | (2) |
|
General Guidelines for Women's Health Maintenance |
|
|
254 | (1) |
|
Management of Abnormal Pap Smears |
|
|
254 | (3) |
|
|
|
257 | (19) |
|
|
|
|
|
|
|
257 | (1) |
|
|
|
258 | (1) |
|
|
|
258 | (2) |
|
|
|
260 | (1) |
|
Diabetes Mellitus (DM) and Pregnancy |
|
|
261 | (1) |
|
Pregnancy-Induced Hypertension (PIH)/ Preeclampsia |
|
|
262 | (1) |
|
|
|
263 | (1) |
|
|
|
263 | (1) |
|
|
|
263 | (2) |
|
|
|
265 | (1) |
|
|
|
266 | (1) |
|
|
|
266 | (1) |
|
Infection of Genitourinary Tract |
|
|
267 | (2) |
|
|
|
269 | (1) |
|
|
|
269 | (1) |
|
Rhesus Factor (Rh) Incompatibility |
|
|
270 | (1) |
|
Genetic/Chromosomal Disorders |
|
|
270 | (1) |
|
|
|
271 | (1) |
|
Postpartum Fever and Sepsis |
|
|
271 | (1) |
|
|
|
272 | (1) |
|
|
|
272 | (1) |
|
|
|
273 | (3) |
|
|
|
276 | (24) |
|
|
|
|
|
276 | (6) |
|
|
|
282 | (8) |
|
|
|
290 | (2) |
|
|
|
292 | (2) |
|
|
|
294 | (1) |
|
|
|
295 | (5) |
|
|
|
300 | (27) |
|
|
|
|
|
|
|
|
|
300 | (2) |
|
Infections of the CNS (Only Plasmodium falciparum Causes CNS Disease) |
|
|
302 | (3) |
|
Infections of the Gastrointestinal Tract |
|
|
305 | (3) |
|
Infections of the Respiratory Tract |
|
|
308 | (2) |
|
|
|
310 | (3) |
|
|
|
313 | (6) |
|
Pathogens With Bioterrorism Potential |
|
|
319 | (8) |
|
|
|
327 | (32) |
|
|
|
|
|
|
|
327 | (1) |
|
Growth and Development Milestones |
|
|
327 | (1) |
|
|
|
327 | (15) |
|
|
|
342 | (3) |
|
|
|
345 | (2) |
|
|
|
347 | (5) |
|
Gastroenterologic Disorders |
|
|
352 | (2) |
|
|
|
354 | (1) |
|
|
|
355 | (1) |
|
|
|
355 | (4) |
|
|
|
359 | (32) |
|
|
|
|
|
|
|
359 | (2) |
|
|
|
361 | (1) |
|
|
|
362 | (2) |
|
|
|
364 | (1) |
|
Gastrointestinal (GI) Disorders |
|
|
365 | (7) |
|
Genitourinary Tract Disorders---Male |
|
|
372 | (1) |
|
Genitourinary Tract Disorders---Female |
|
|
373 | (4) |
|
|
|
377 | (1) |
|
|
|
378 | (1) |
|
|
|
379 | (1) |
|
|
|
380 | (5) |
|
|
|
385 | (1) |
|
|
|
386 | (5) |
|
|
|
391 | (13) |
|
|
|
|
|
|
|
391 | (1) |
|
|
|
391 | (1) |
|
|
|
391 | (1) |
|
|
|
392 | (1) |
|
|
|
392 | (12) |
|
|
|
404 | (24) |
|
|
|
|
|
|
|
|
|
|
|
404 | (1) |
|
|
|
405 | (1) |
|
Principles of Drug-Drug Interactions |
|
|
405 | (1) |
|
|
|
405 | (2) |
|
Cardiovascular Agents and Antihypertensive Agents |
|
|
407 | (5) |
|
|
|
412 | (1) |
|
|
|
412 | (2) |
|
|
|
414 | (3) |
|
|
|
417 | (1) |
|
|
|
417 | (2) |
|
|
|
419 | (2) |
|
|
|
421 | (2) |
|
|
|
423 | (2) |
|
Cancer Chemotherapeutic Agents |
|
|
425 | (3) |
|
Ethical and Legal Considerations |
|
|
428 | (21) |
|
|
|
|
|
AAPA-LAPS Guidelines for PA Ethical Conduct |
|
|
428 | (3) |
|
Essence of Clinical Ethics |
|
|
431 | (2) |
|
|
|
433 | (2) |
|
Primary Ethical Obligations |
|
|
435 | (3) |
|
|
|
438 | (7) |
|
|
|
445 | (4) |
| Index |
|
449 | |
